From its headquarters in Massachusetts (US), Hologic embarks on a clear mission to enable healthier lives everywhere, every day, for women worldwide. To achieve this, it offers a range of leading healthcare products in three domains that align with Hologic’s divisions: Breast & Skeletal Health, Diagnostic and Gynecological Surgical. The company’s main focus is on early screening and detection and treatment of health disorders in women. With locations in over 15 countries, including the new mainland Europe facility in Zaventem and more than 6,500 employees globally, Hologic empowers healthy lives around the world.
The company’s track record is nothing but remarkable. Since its early beginnings, Hologic has taken the lead in developing groundbreaking technologies that have truly shaped the future of woman’s medicine as we know it today, from nucleic acid amplification tests as well as cervical and breast cancer screening to osteoporosis assessment and advanced breast biopsy techniques. “Innovation runs through our veins and is fueled by knowledge, passion, collaboration and integrity as we work to improve women’s health,” asserts Ian Eggs, VP of Service & Sales Enablement EMEAC at Hologic.